Nikolai Alexandrovich Nozdrachev

Nikolai Alexandrovich Nozdrachev

Auto-generated profile, based on publicly available information

Nikolai Alexandrovich Nozdrachev

Altai State Medical University

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 December 2024 in Experimental and Сlinical Urology
Verified
Journal Article
Open access
RBRussia Barnaul
Russia Barnaul
NNN.A. Nozdrachev
N.A. Nozdrachev
BNB.A. Neymark
B.A. Neymark
ANA.B. Neymark
A.B. Neymark
FSF.A. Sevryukov
F.A. Sevryukov
YKYu.S. Kovaleva
Yu.S. Kovaleva
Introduction. The course of the postoperative period in patients with benign prostatic hyperplasia (BPH) who have undergone transurethral resection (TUR) remains an important issue. Adequate relaxation of the muscle tone of the prostatic urethra and bladder neck is crucial in the postoperative period. Materials and methods. The article presents the results of the study evaluating the drug Prostatex plus in patients with BPH who underwent transurethral resection of the prostate (TURP). Results. The results showed the most significant efficacy of Prostatex Plus when it was taken pre- and postoperatively (5 days before and 10 days after TURP) for patients with BPH if compared with the purely postoperative use of indomethacin and Prostatex Plus (10 days after TURP). The efficacy is confirmed by significantly improved urinary flow and the best pain relief in the postoperative period. Thus, the drug should be prescribed for the pre- and postoperative management of these patients. Conclusion. The use of Prostatex Plus can significantly improve the quality of life of patients in the postoperative period after TURP for BPH.

1 January 2020 in Scientific and Practical Journal Healthcare of Kyrgyzstan
Verified
Journal Article
Closed access
ANAlexander Izrailevich Neymark
Alexander Izrailevich Neymark
MTMikhail Alexandrovich Tachalov
Mikhail Alexandrovich Tachalov
BNBoris Alexandrovich Neymark
Boris Alexandrovich Neymark
VLVladimir Pavlovich Levin
Vladimir Pavlovich Levin
NNNikolai Alexandrovich Nozdrachev
Nikolai Alexandrovich Nozdrachev

1 January 2026 in Bulletin of Medical Science
Verified
Journal Article
Open access
ANAlexander I. Neymark
Alexander I. Neymark
NNNikolay A. Nozdrachev
Nikolay A. Nozdrachev
SBSergey S. Belokurov
Sergey S. Belokurov
BNBoris A. Neymark
Boris A. Neymark
In the context of modern medical development, when endoscopic approaches to the treatment of urolithiasis are actively being implemented, therapeutic strategies aimed at evacuating small stones and their fragments from the kidneys and upper urinary tract, as well as nephroprotective measures, are gaining new relevance. The use of herbal preparations with pronounced urolithic and nephroprotective properties is quite promising for the therapy of urolithiasis due to their high efficacy and safety. One of the representatives of this group of drugs is Nephrobiolic. Objective.Evaluation of the efficacy and safety of the Nephrobiolic complex as a lithokinetic and nephroprotective therapy in patients after retrograde pyelolithotripsy. Materials and Methods. The study included 30 patients with stone localization in the renal collecting system. By the method of typological selection, the patients were divided into 2 groups of 15 people each, comparable in age, stone size, and clinical data. All study participants underwent Multislice Computed Tomography (MSCT) of the kidneys with recording of the size, contour of the stone, and its density. The size of the stone did not exceed 10 mm in diameter. The density of the stones ranged from 600 to 1500 HU. All patients underwent scheduled kidney stenting on the affected side 10-12 days prior. As part of inpatient treatment, they underwent laser retrograde pyelolithotripsy. Before the surgery, two days after the surgery, and thirty days after the surgery, all patients underwent the necessary examination. As postoperative therapy, patients received drugs of the following classes: nonsteroidal anti-inflammatory drugs (NSAIDs), uroseptics, antispasmodics, dietary therapy, and, if necessary, antibacterial therapy. Patients in group 2 additionally received Nephrobiolic at 2 capsules 2 times a day for 1 month (5–7 days before surgery + 23–25 days after surgical treatment (pieholithotripsy)), with subsequent follow-up observation for 1 month. Results. The passage of stone fragments after retrograde intrarenal surgery (RIRS) was more effectively observed in the group receiving Nephrobiolic. When assessing the level of urine enzymes (alkaline phosphatase (ALP), lactate dehydrogenase (LDH), gamma-glutamyltransferase (GGT), and leucine aminopeptidase (LAP)) in all patients after lithotripsy, an increase in enzymeuria was noted in both groups, more pronounced in group 1, indicating damage to the kidney cell membranes due to the surgical intervention. When assessing the level of enzymuria in the remote period, in the 2nd group of patients this indicator returned to baseline (pre-intervention) values, in the 1st group – a moderate increase in the level of enzymuria persisted. Conclusion. Nephrobiolic promotes a more effective and less painful expulsion of stone fragments after retrograde pyelolithotripsy. This phytocomplex is capable of protecting kidney tissue from the damaging effects of lithotripsy and is characterized by a high degree of safety, which is very important during nephroprotective and lithokinetic therapy.

1 January 2025 in Bulletin of Medical Science
Verified
Journal Article
Open access
ANAlexander I. Neymark
Alexander I. Neymark
BNBoris A. Neymark
Boris A. Neymark
NNNikolay A. Nozdrachev
Nikolay A. Nozdrachev
ALAnna N. Larionova
Anna N. Larionova
The problem of urolithiasis treatment remains relevant and complex in modern urology. Phytopreparations are one of the leading means used as preoperative preparation and postoperative management in patients with urolithiasis. Objective. To evaluate Pinabin in patients with urolithiasis after retrograde contact pyelolithotripsy. Materials and Methods. The study included 30 patients with urolithiasis with stone localization in the pelvis of the kidney, without impaired urine outflow. The patients were divided into 3 groups. All patients underwent retrograde contact pyelolithotripsy. Patients in group 1 received NSAIDs, uroseptic, antispasmodics, diet therapy, and, if necessary ABT; patients of group 2 received NSAIDs, uroseptic, antispasmodics, diet therapy, and Pinabin 5 drops 3 times a day with meals for 1 month; patients of group 3 received monotherapy with Pinabin 5 drops 3 times a day with meals for 1 month. Results. In the course of observation, the high efficacy of pinabin in prevention of infectious-inflammatory complications and detachment of concrement fragments was observed after retrograde contact lithotripsy. The safety of using this complex in patients with urolithiasis was proved. Conclusion. Pinabin can be recommended to patients with urolithiasis after retrograde contact lithotripsy as a lithokinetic agent and as a way to prevent infectious-inflammatory complications.

1 January 2022 in Russian Journal of Human Reproduction
Verified
Journal Article
Closed access
ELE.I. Lebedeva
E.I. Lebedeva
SYS.D. Yavorskaya
S.D. Yavorskaya
ANA.I. Neymark
A.I. Neymark
NFN.I. Fadeeva
N.I. Fadeeva
NNN.A. Nozdrachev
N.A. Nozdrachev
BNB.A. Neymark
B.A. Neymark

1 January 2020 in Фармакология & Фармакотерапия
Verified
Journal Article
Closed access
ANAlexander Izrailevich Neymark
Alexander Izrailevich Neymark
BNB.A. Neymark
B.A. Neymark
NNN.A. Nozdrachev
N.A. Nozdrachev
ADA.V. Davydov
A.V. Davydov
IKI.V. Kablova
I.V. Kablova
VLV.P. Levin
V.P. Levin